Skip to main content
Speech

Deputy Assistant Attorney General Michael Kades Delivers Remarks at GCR Live: Law Leaders Global 2024

Location

Miami, FL
United States

Remarks as Prepared for Delivery

Thank you[1] , Josh, for the kind introduction. And thank you for not mentioning how much of a pain in the neck I was when we were both attorney advisors at the Federal Trade Commission.

I was recently in Milwaukee, Wisconsin. My daughter and I had tea at the top of the Pfister Hotel, where we looked out at the Federal Courthouse, where I clerked, including the window of my “office.”

I could not help but tell her various stories of my clerkship with Judge Reynolds: like the time a citizen upset with the judge’s busing decision ran into the court room brandishing a saber — that was before my time — or the time the judge threatened his children that if they didn’t stop bickering, I would get his tickets to the NFC championship game at Lambeau field — not surprisingly, they found common ground quickly.

My fondest memories, however, were sitting in his office, often late at night when the courthouse was empty, discussing the individual cases. Like wanderers in the countryside, we would meander from facts to policy to morality to research and back again. Then, at some point, Judge Reynolds would ask, “What does the statute (or case law) say?” At this point, I had long forgotten what the exact words were. I would respond, “I don’t remember exactly.” And, he would smile and say, “It never hurts to read the law.” Invariably, re-reading the law or the cases would reveal a key phrase I had overlooked or that I had added words that were not there.

You might think the point of my opening story is that policy and research do not matter. But the story has a second part. Finally, after one of these long sessions, I asked the Judge, why don’t we start with the text of the statute? Wouldn’t that be faster? With an indulgent smile and a twinkle in his eye, he would say, “Michael, we have to do both.”

In honor of Judge Reynolds, I want to focus on both: the text of Section 7 of the Clayton Act and the economic consensus supporting the structural presumption.

Why these two topics? Because they are two of the most contentious issues in merger litigation: the government’s burden and the value of the structural presumption.

First, the Clayton Act prohibits mergers that may substantially lessen competition. That text prohibits mergers as long as competitive harm is reasonably probable — even if harm is unlikely in the sense of less than 50%. That text requires skepticism of rebuttal evidence. And, that text reflects an error cost judgment in favor of enforcement.

Second, modern economic theory and empirical work support continued reliance on the structural presumption — the structural presumption is more than good law, its good policy.

Let’s start with the statute.[2] It says “may” — not that the effect “is to substantially lessen competition,”[3] not the effect “is possibly to substantially lessen competition,” and not that the effect “is certain to substantially lessen competition.” [4] Congress considered all these alternatives. But the word they chose was “may.” Specifically, Congress changed the language from “where the effect is” to “where the effect may be,” which Senator Chilton explained meant “where it is possible for the effect to be.”[5]

As the Supreme Court has repeatedly stated, this standard requires only a “reasonable probability” of substantially lessening competition. Reasonable probability does not mean any possibility. For example, the chance that the United States would defeat the USSR in Hockey at the 1980 Olympics was not a reasonable probability — there is reason it is called the Miracle on Ice.

In California v. American Stores, the Supreme Court’s last discussion of the standard, they not only quoted the “may be” in the Clayton Act, they italicized it, and they added that these words create “a relatively expansive definition of antitrust liability.”[6]

The Court has also described the standard as requiring plaintiffs to prove the acquisition creates a threat of competitive harm. As described in General Dynamics, successful rebuttal evidence “mandate[s] a conclusion that no substantial lessening of competition [is] threatened by the acquisition.”[7] The D.C. Circuit in Baker Hughes relied on a similar formulation.[8] Rebuttal evidence must ameliorate the threat of substantially lessening competition. The Court is talking about the risk of an anticompetitive effect.

The case law confirms the plain meaning of the statute: Section 7 does not require that the harm be more likely than not. As long as the harm is reasonably probable,[9] Section 7 bars some mergers that are more likely than not to have no — or even a positive — effect on competition.

And as Doctor Steven Salop has pointed out, when combined with the burden of proof, it means the government must prove by a preponderance of the evidence that the acquisition “may substantially lessen competition.”[10]

This insight has at least two important implications for merger review. First, those hostile to merger enforcement have long complained that the government wants it both ways. In its case, the government relies on the probability of harm but then demands greater certainty from defendants’ rebuttal evidence.[11]

The text of Section 7, not a policy judgment, mandates the difference. Evidence that entry or efficiencies may occur, or can occur or are even likely to occur can all be consistent with a transaction that may, or threatens to, substantially lessen competition.

There continues to be a debate about whether efficiencies are cognizable under Section 7. Even if they are, however, the legal question is whether evidence about efficiencies is strong enough that the acquisition does not threaten substantial harm.

Second, “may” reflects a policy judgment from Congress — that stopping harmful acquisitions is more important on the margin than allowing benign or even procompetitive ones. Ever since Judge Easterbrook’s “The Limits of Antitrust,”[12] introduced the concept of error-cost analysis, it has been de rigueur for scholars, attorneys and courts to intone gravely about “false positives,” “false negatives,” “type-one errors,” and “type-two errors” as intellectual badges of honor. Take away the technical jargon, Judge Easterbrook was simply saying overenforcement of the antitrust laws is more dangerous than their underenforcement.

Let’s set aside the broad range of scholars that have questioned Judge Easterbrook’s thesis as a general principle.[13] The problem with academics and enforcers deciding for themselves what error-cost judgment to make is that Congress has already made that judgment, and it is to err on the side of preventing anticompetitive mergers.[14]  

None of this means the government has no burden or that courts should ignore evidence on how an acquisition can improve competition in the relevant market. Rather, the points are:

  1. If we read the statute, the word “may” exists and must be given meaning.
  2. The legal question is not predicting the most likely future but whether an anticompetitive effect is reasonably probable.
  3. Entry, efficiencies, and other rebuttal evidence may still be relevant but the government prevails if a threat to competition exists despite that evidence.

Reading the statute matters, but so does the research. For 60 years, courts have applied a structural presumption: mergers are presumptively illegal when they significantly increase concentration in highly concentrated markets.[15]

That is an undeniable statement of the law, whether one focuses on binding Supreme Court precedent or on recent district court opinions.[16]

As part of our guideline process, we also looked at the economic literature relating to the structural presumption. What we found — and I know this will be a surprise to at least some you in the audience — an economic consensus supports that presumption.

In a field still rife with debates and disagreements, a remarkable number of economists have written in recent years to defend reliance on structural presumptions. Let me give you a few examples:

  1. “Economic theory provides support for the established legal presumption that a merger in a market is likely to have adverse competitive effects when it occurs in a concentrated market and makes it more concentrated (i.e., increases the HHI).”[17] 26 economists co-authored that paper in 2022, including leaders of economics at the antitrust agencies from both Republican and Democratic administrations.
  2. “First and foremost, economic theory and a wide range of economic evidence support the conclusion that horizontal mergers that significantly increase market concentration are likely to lessen competition and harm consumers by raising prices, reducing output, or limiting product quality or innovation.”[18] That’s from a recent Yale Law Journal paper by Carl Shapiro and Herbert Hovenkamp.
  3. “[O]ne important conclusion is straightforward . . . greater concentration can be expected to make coordination more likely, stronger, or more effective. Accordingly, our analysis supports a structural merger policy, by which mergers between rivals that increase concentration significantly in a concentrated market are presumed to harm competition.”[19] That’s from a recent contribution by Jon Baker and Joe Farrell.

Those three articles cover dozens of economists across the ideological divide, theorists and empiricists, academic economists and economists with public policy expertise.

A number of recent merger retrospectives link increased concentration to observed post-merger anticompetitive effects such as increased prices and decreased product availability. Those studies cover consumer package goods, grocery stores, hospitals, health care providers, health insurers and mergers in oligopoly markets.[20]

There are of course opponents to this view. For example, in a 2016 article by Joshua Wright and Douglas Ginsburg, the authors wrote “that defining the relevant market and calculating market shares are generally not useful tools for predicting the likely competitive effects of a proposed transaction.”[21] In some cases, these critics are loud and well-funded by companies with an interest in limiting merger enforcement.[22]

So, when we prepared the revisions to the merger guidelines, we looked closely across the bibliography of academic and economic work that all commenters, supportive or critical, submitted on this question. What we found is that the structural presumption is better supported in the empirical and economic literature today than it has ever been.

What is the disconnect? Here, we need a little history. In the 1950s, a number of papers found a correlation between structure, conduct and performance, which led to the Structure-Conduct-Performance paradigm in Industrial Organizations. Those papers suffered from serious flaws, however. In general, one cannot infer that concentration causes higher prices. This became well accepted in the 1970s and 1980s, as empirical work by Harold Demsetz (DEM sets) and others refuted the idea that the structure of a market determines its performance.[23] That was an important advance, recognizing that many factors — including the economics of the industry — can cause an industry to become concentrated.

What started as good and valuable economic work was eventually overread to argue for underenforcing the antitrust laws. Like some others, Ginsburg and Wright point to that economic literature and argue it refutes structural measures in merger review.[24] But of course, Demsetz’s empirical work refuted the correlation between all causes of concentration and performance, not the correlation between merger-induced concentration and the risk of that merger lessening competition.

The important finding of the Structure Conduct Performance work in the 1970s and 1980s was that competition on the merits can cause concentration. But merger enforcement depends on a different question: what happens when mergers cause concentration. On that point, the economic literature is clear. Both as a matter of theory and empirically, mergers that increase concentration in highly concentrated markets are likely to have adverse effects.[25] Not just that it may, but that is likely.  

Of course, any structural presumption will involve some amount of line drawing (why is a market with an HHI of 1800 highly concentrated but 1799 is not). It would be too much to ask empirical work to provide exact cut-offs. The empirical work available today, however, would arguably support even more stringent thresholds than we adopted in the 2023 Merger Guidelines.[26] We chose 1800 and 100 because, even if it is conservative, it is well-supported by this literature and by the many appellate decisions across multiple circuits that reference those thresholds.[27]

The very first merger-decision after we released the draft Guidelines, FTC v. IQVIA, explicitly rejected the defense bar’s criticisms of the 30% presumption in the guidelines.[28] The court relied on Philadelphia National Bank to find that the merging parties’ 30.6% market share triggered a structural presumption. Judge Ramos was correct on both the law and the economics.

Besides allowing me to wax nostalgic about clerking for Judge Reynolds in Milwaukee, returning to basic principles is valuable. It reminds us of what we know and allows us to re-evaluate them. Congress’s decision to use “may” matters. Those three letters define the government’s burden, frame the role of rebuttal evidence, and provide a policy judgment on the value of enforcement. Whether one likes the structural presumption or not, it is undeniably good law. It is also backed by an economic consensus, as strong as it has ever been.

Those two principles guide our work. Congress crafted Section 7 as a risk assessment and not a crystal ball. And the structural presumption remains an important tool in assessing mergers.

Thank you for your time.


[1] I want to thank Eric Dunn, Susan Athey, David Lawrence, John Sullivan, Danielle Drory, and Ryan Danks who each provided invaluable help in preparing this speech.

[2][2] 15 U.S.C. § 18.

[3] The ABC’s of Clayton 7: Amendment of 1950; Brown Shoe; The Court and Current Complexities, 10 VILL. L. REV. 734 (1965), available at https://digitalcommons.law.villanova.edu/cgi/viewcontent.cgi?referer‌=&httpsredir=1&article=1686&context=vlr.

[4] Brown Shoe Co. v. United States, 370 U.S. 294, 323 (1962) (citing H.R. Hearings on H.R. 2734, at 74; S. Hearings on H.R. 2734, at 32, 33, 160–168; 96 Cong. Rec. 16453, 16502).

[5] 3 THE LEGISLATIVE HISTORY OF THE FEDERAL ANTITRUST LAWS AND RELATED STATUTES 2629 (Earl W. Kintner ed., 1978). I am grateful to Steven Salop and Daniel Francis for calling attention to this legislative history. See Steven C. Salop, The Appropriate Decision Standard for Section 7 Cases, 53 U. BALT. L. REV. (forthcoming) (manuscript at 11 & n.52), available at https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4675289.

[6] California v. Am. Stores Co., 495 U.S. 271, 284 (1990).

[7] United States v. Gen. Dynamics Corp., 415 U.S. 486, 498 (1974).

[8] United States v. Baker Hughes Inc., 908 F.2d 981, 991 (D.C. Cir. 1990).

[9] See Strickler v. Greene, 527 U.S. 263, 264 (1999) (clarifying that “reasonable probability” is less demanding than “more likely than not”); Kyles v. Whitley, 514 U.S. 419, 434 (1995) (noting, in the Brady disclosure context, that a “reasonable probability” does not require “more likely than not” proof because “the adjective is important”); United States v. Hebshie, 549 F.3d 30, 44 (1st Cir. 2008) (reasonable probability standard “is not the same as, and should not be confused with” a more-likely-than-not standard (citing United States v. Dominguez Benitez, 542 U.S. 74, 83 n. 9 (2004))); United States v. Bertelsmann SE & Co. KgaA, 646 F. Supp. 3d 1, 22 n.15 (D.D.C. 2022) (noting that the preponderance of the evidence standard is layered on top of Section 7’s already probabilistic standard”); see also Strickler, 527 U.S. at 300 & n.3 (Souter, J., concurring in part) (observing that “significant possibility” better captures concept intended by “reasonable probability,” and noting Clayton Act’s “reasonable probability” standard); Brown Shoe, 370 U.S. at 323 (“Congress used the words ‘may be substantially to lessen competition’ . . . to indicate that its concern was with probabilities, not certainties.”).

[10] See Salop, supra note 5, at 3.

[11] See, e.g., Daniel A. Crane, Rethinking Merger Efficiencies, 110 MICH. L. REV. 347, 356–57 (2011) (“The Guidelines implicitly treat efficiencies and anticompetitive risks asymmetrically by insisting that efficiencies be proven to a very high degree of certainty in order to justify a merger whereas risks need not be proven with great certainty in order to block a merger.”).

[12] Frank H. Easterbrook, The Limits of Antitrust, 63 TEX. L. REV. 1 (1984).

[13] See Salop, supra note 5., at 17; Jonathan B. Baker, Taking the Error Out of “Error Cost” Analysis: What’s Wrong with Antitrust’s Right, 80 ANTITRUST L.J. 1 (2015); Herbert Hovenkamp, Antitrust Error Costs, 24 U. PA. J. BUS. L. 293 (2022), Alan Devlin & Michael Jacobs, Antitrust Error, 52 WM. & MARY L. REV. 75 (2010), Michael Kades, Competitive Edge: Underestimating the Cost of Underenforcing U.S. Antitrust Laws, EQUITABLE GROWTH (Dec. 13, 2019), https://equitablegrowth.org/competitive-edge-underestimating-the-cost-of-underenforcing-u-s-antitrust-laws/.

[14] See 3 THE LEGISLATIVE HISTORY OF THE FEDERAL ANTITRUST LAWS AND RELATED STATUTES, supra note 5, at 2629 (noting that the final version of Section 7 reflected a compromise between the House and Senate that changed the language from “where the effect is” to “where the effect may be”).

[15] See FTC v. Hackensack Meridian Health, Inc., 30 F.4th 160, 173 (3d Cir. 2022) (“The District Court correctly concluded that these numbers [showing that the market was highly concentrated and the merger would result in a significant increase in concentration] demonstrate the merger is presumptively anticompetitive.”); FTC v. Penn State Hershey Medical Center, 838 F.3d 327, 347 (3d Cir. 2016) (“The Government can establish a prima facie case simply by showing a high market concentration based on HHI numbers.”); Saint Alphonsus Med. Ctr.-Nampa Inc. v. St. Luke’s Health Sys., Ltd., 778 F.3d 775, 788 (9th Cir. 2015) (“The extremely high HHI on its own establishes the prima facie case.”); ProMedica Health Sys. Inc v. FTC, 749 F.3d 559, 570 (6th Cir. 2014) (applying the structural presumption based on “the strong correlation between market share and price, and the degree to which this merger would further concentrate markets that are already highly concentrated”); FTC v. H.J. Heinz Co., 246 F.3d 708, 716 (D.C. Cir. 2001) (“Sufficiently large HHI figures establish the FTC’s prima facie case that a merger is anticompetitive”); FTC v. Elders Grain, 868 F.2d 901, 906 (7th Cir. 1989) (“[A]n acquisition which reduces the number of significant sellers in a market already highly concentrated and prone to collusion by reason of its history and circumstances is unlawful in the absence of special circumstances.”); FTC v. IQVIA Holdings Inc., No. 23 CIV. 06188 (ER), 2024 WL 81232, at *33 (S.D.N.Y. Jan. 8, 2024) (holding that the FTC met its prima facie burden by establishing the structural presumption by both HHI levels and a relevant market share above 30% and noting that defendants’ arguments that the presumption had been “repudiated” were “directly contradict[ed]” by Second Circuit precedent).

[16] See supra, note 15. Since 2010, dozens of district courts have applied the structural presumption in evaluating proposed mergers. See, e.g., United States v. JetBlue Airways Corp., No. CV 23-10511-WGY, 2024 WL 162876, at *15 n.34 (D. Mass. Jan. 16, 2024); IQVIA Holdings, 2024 WL 81232, at *33; Bertelsmann, 646 F. Supp. 3d at 37–38; FTC v. Hackensack Meridian Health, Inc., No. CV 20-18140, 2021 WL 4145062, at *20 (D.N.J. Aug. 4, 2021); New York v. Deutsche Telekom AG, 439 F.Supp.3d 179 (S.D.N.Y. 2020); FTC v. Peabody Energy Corp., 492 F. Supp. 3d 865, 903 (E.D. Mo. 2020); FTC v. Sanford Health, Sanford Bismarck, No. 1:17-CV-133, 2017 WL 10810016, at *12 (D.N.D. Dec. 15, 2017); FTC v. Wilh. Wilhelmsen Holding ASA, 341 F. Supp. 3d 27, 47 (D.D.C. 2018); FTC v. Advoc. Health Care, No. 15 C 11473, 2017 WL 1022015, at *7 (N.D. Ill. Mar. 16, 2017); United States v. Energy Sols., Inc., 265 F. Supp. 3d 415, 442 (D. Del. 2017); United States v. Trib. Publ’g Co., No. CV1601822ABPJWX, 2016 WL 2989488, at *5 (C.D. Cal. Mar. 18, 2016); United States v. Bazaarvoice, Inc., No. 13-CV-00133-WHO, 2014 WL 203966, at *70 (N.D. Cal. Jan. 8, 2014); United States v. H & R Block, Inc., 833 F. Supp. 2d 36, 72 (D.D.C. 2011).

[17] Nathan Miller et al., On The Misuse of Regressions of Price on the HHI in Merger Review, 10 J. ANTITRUST ENFORCEMENT 248, 251 (2022).

[18] Herbert Hovenkamp & Carl Shapiro, Horizontal Mergers, Market Structure, and Burdens of Proof, 127 Yale L.J. 1996, 2006 (2018).

[19] Jonathan B. Baker & Joseph Farrell, Oligopoly Coordination, Economic Analysis, and the Prophylactic Role of Horizontal Merger Enforcement, 168 U. Pa. L. Rev. 1985, 1991 (2020).

[20] See generally Vivek Bhattacharya, Gaston Illanes, & David Stillerman, Merger Effects and Antitrust Enforcement: Evidence from US Consumer Packaged Goods (Nat’l Bureau of Econ. Rsch., Working Paper No. 31123, 2023), https://www.nber.org/papers/w31123 (studying 50 mergers in the consumer-packaged goods industry and finding that, on average, these mergers raised prices by 1.5 percent and decreased quantities sold by 2.3 percent, on average); Daniel Hosken, Luke Olson, & Loren Smith, Do Retail Mergers Affect Competition? Evidence from Grocery Retailing, 27 J. ECON & MGMT. STRATEGY 3 (2018) (finding that the majority of grocery mergers in highly concentrated markets resulting in price increases of more than 2 percent); JOHN E. KWOKA, JR., MERGERS, MERGER CONTROL, AND REMEDIES: A RETROSPECTIVE ANALYSIS OF U.S. POLICY 110–11 (2015) (providing a meta-analysis of retrospective literature, finding that more than 80 percent of mergers resulted in price increases and the mean price increase was 5.88 percent across all studied transactions); Orley C. Ashenfelter, Daniel Hosken & Matthew C. Weinberg, Did Robert Bork Understate the Competitive Impact of Mergers? Evidence from Consummated Mergers, 57 J.L. & ECON. S67 (2014) (reviewing prior retrospectives and concluding that mergers in oligopolistic markets can result in economically meaningful price increases, as 36 of the 49 studies found evidence of merger induced price increases); Leemore Dafny, Mark Duggan, & Subramaniam Ramanarayanan, Paying a Premium on Your Premium? Consolidation in the US Health Insurance Industry, 102 AM. ECON. REV. 1161 (2012) (examining healthcare mergers and finding the mean increase in local market HHI during the studied period raised premiums by roughly 7 percent); Orley Ashenfelter & Daniel Hosken, The Effect of Mergers on Consumer Prices: Evidence from Five Mergers on the Enforcement Margin, 53 J.L. & ECON. 417 (2010) (examining a set of mergers that were unchallenged by the government finding that the majority resulted in a significant increase in consumer prices in the short run); Thomas Koch & Shawn W. Ulrick, Price Effects of a Merger: Evidence from a Physicians’ Market, 59 ECON. INQUIRY 567 (2021) (concluding that a merger of orthopedic physicians’ practices increased prices to some payors by 10 to 20 percent while prices in nearby areas not affected by the merger remained unchanged); Zack Cooper et al., The Price Ain’t Right? Hospital Prices and Health Spending on the Privately Insured, 134 Q.J. ECON. 51 (2019) (examining 366 hospital mergers and finding that prices increased by over 6 percent when merging hospitals were geographically close); Elena Prager & Matt Schmitt, Employer Consolidation and Wages: Evidence from Hospitals, 111 AM. ECON. REV. 397 (2021) (examining hospital mergers and finding reduced wage growth when merger significantly increases concentration).

[21] Douglas H. Ginsburg & Joshua D. Wright, Philadelphia National Bank: Bad Economics, Bad Law, Good Riddance, 80 ANTITRUST L.J. 377, 384 (2015). Ginsburg and Wright claimed this reflected a “consensus” based on two sources, the 2006 Commentary on the Merger Guidelines and Carl Shapiro, The 2010 Horizontal Merger Guidelines: From Hedgehog to Fox in Forty Years, 77 ANTITRUST L.J. 49 (2010). Shapiro, however, was pointing out that other economic tools such as diversion ratios and upward pricing models are better indicators of unilateral effects than market shares. He also explained, “the Agencies place considerable weight on HHI measures in cases involving coordinated effects.” Id. at 56; see also note 17, supra.

[22] See, e.g., Daisuke Wakabayashi, Big Tech Funds a Think Tank Pushing for Fewer Rules. For Big Tech., N.Y. TIMES (July 24, 2020), https://www.nytimes.com/2020/07/24/technology/global-antitrust-institute-google-amazon-qualcomm.html.

[23] See, e.g., Harold Demsetz, Two Systems of Belief About Monopoly, in INDUSTRIAL CONCENTRATION: THE NEW LEARNING 164 (Harvey Goldschmid et al. eds., 1974); see also Matthew Panhans, The Rise, Fall, and Legacy of the Structure-Conduct-Performance Paradigm 8–9, J. HIST. ECON. THOUGHT (2023) (describing Demsetz’s and others’ critiques of the structure-conduct-performance paradigm during the 1970s).

[24] See Ginsburg & Wright, supra note 20, at 383–84. But see Panhans, supra note 22, at 12 (recognizing the continuing value of structure in understanding the risk of tacit collusion).

[25] See, e.g., John E. Kwoka, Jr., The Structural Presumption and the Safe Harbor in Merger Review: False Positives or Unwarranted Concerns?, 81 ANTITRUST L.J. 837, 857–72 (2017) (finding that empirical data from past mergers confirms that concentration over a certain threshold produces anticompetitive effects); Bhattacharya, Illanes, & Stillerman, supra note 19, at 2 (“We find evidence favoring the Guidelines’ use of both [HHI and change in the HHI] in screening. Price changes of consummated mergers are positively correlated with average DHHI across markets; within-merger, price changes in a geographic market correlate with HHI and DHHI in that market.”).

[26] See Kwoka, supra note 24, at 857–72; see also David W. Berger et al., Merger Guidelines for the Labor Market 26–31 (Nat’l Bureau of Econ. Rsch., Working Paper No. 31147, 2023) (finding that, by simulating a representative set of mergers in the U.S., more stringent HHI thresholds lead to better outcomes for workers); Volker Nocke and Michael D. Whinston, Concentration Thresholds for Horizontal Mergers, 112 AM. ECON. REV. 1915 (2022) (concluding that the 2010 Horizontal Merger Guidelines’ structural presumption levels were likely too lax to prevent consumer harm from unilateral price effects).

[27] U.S. Dep’t of Justice and Fed. Trade Comm’n, Merger Guidelines 6 n.15 (2023) (citing Chicago Bridge & Iron Co. N.V. v. FTC, 534 F.3d 410, 431 (5th Cir. 2008); FTC v. H.J. Heinz Co., 246 F.3d 708, 716 (D.C. Cir. 2001); FTC v. Univ. Health, Inc., 938 F.2d 1206, 1211 (11th Cir. 1991)).

[28] FTC v. IQVIA Holdings Inc., No. 23 CIV. 06188 (ER), 2024 WL 81232, at *33 (S.D.N.Y. Jan. 8, 2024).


Topic
Antitrust
Updated February 1, 2024